| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | alpha-amylase activity | 9.30e-11 | 5 | 43 | 4 | GO:0004556 | |
| GeneOntologyMolecularFunction | chloride ion binding | 1.56e-10 | 16 | 43 | 5 | GO:0031404 | |
| GeneOntologyMolecularFunction | amylase activity | 2.79e-10 | 6 | 43 | 4 | GO:0016160 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 8.49e-08 | 103 | 43 | 6 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 6.20e-07 | 144 | 43 | 6 | GO:0016798 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 5.11e-06 | 16 | 43 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | apolipoprotein binding | 1.03e-05 | 20 | 43 | 3 | GO:0034185 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 1.20e-05 | 21 | 43 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | toxin transmembrane transporter activity | 2.95e-04 | 12 | 43 | 2 | GO:0019534 | |
| GeneOntologyMolecularFunction | coreceptor activity | 5.00e-04 | 72 | 43 | 3 | GO:0015026 | |
| GeneOntologyMolecularFunction | Wnt receptor activity | 6.04e-04 | 17 | 43 | 2 | GO:0042813 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 8.12e-04 | 85 | 43 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | cytoskeletal anchor activity | 1.21e-03 | 24 | 43 | 2 | GO:0008093 | |
| GeneOntologyMolecularFunction | Wnt-protein binding | 2.43e-03 | 34 | 43 | 2 | GO:0017147 | |
| GeneOntologyMolecularFunction | frizzled binding | 3.69e-03 | 42 | 43 | 2 | GO:0005109 | |
| GeneOntologyMolecularFunction | amide binding | 3.84e-03 | 299 | 43 | 4 | GO:0033218 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.10e-03 | 749 | 43 | 6 | GO:0005509 | |
| GeneOntologyBiologicalProcess | oligosaccharide metabolic process | 1.36e-05 | 70 | 43 | 4 | GO:0009311 | |
| GeneOntologyBiologicalProcess | negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation | 2.54e-05 | 4 | 43 | 2 | GO:1903912 | |
| GeneOntologyBiologicalProcess | positive regulation of translation in response to endoplasmic reticulum stress | 4.23e-05 | 5 | 43 | 2 | GO:0036493 | |
| GeneOntologyBiologicalProcess | Norrin signaling pathway | 4.23e-05 | 5 | 43 | 2 | GO:0110135 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal cell proliferation | 5.74e-05 | 36 | 43 | 3 | GO:0002053 | |
| GeneOntologyBiologicalProcess | establishment of blood-retinal barrier | 6.33e-05 | 6 | 43 | 2 | GO:1990963 | |
| GeneOntologyBiologicalProcess | retinal blood vessel morphogenesis | 6.33e-05 | 6 | 43 | 2 | GO:0061304 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell proliferation | 1.13e-04 | 45 | 43 | 3 | GO:0010464 | |
| GeneOntologyBiologicalProcess | negative regulation of PERK-mediated unfolded protein response | 1.18e-04 | 8 | 43 | 2 | GO:1903898 | |
| GeneOntologyBiologicalProcess | eiF2alpha phosphorylation in response to endoplasmic reticulum stress | 1.18e-04 | 8 | 43 | 2 | GO:0036492 | |
| GeneOntologyBiologicalProcess | regulation of translation initiation in response to endoplasmic reticulum stress | 1.18e-04 | 8 | 43 | 2 | GO:0036491 | |
| GeneOntologyBiologicalProcess | positive regulation of translation in response to stress | 1.18e-04 | 8 | 43 | 2 | GO:0032056 | |
| GeneOntologyBiologicalProcess | signal complex assembly | 1.18e-04 | 8 | 43 | 2 | GO:0007172 | |
| GeneOntologyBiologicalProcess | mesodermal cell migration | 1.51e-04 | 9 | 43 | 2 | GO:0008078 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron projection development | 1.63e-04 | 249 | 43 | 5 | GO:0010976 | |
| GeneOntologyBiologicalProcess | cerebral cortex cell migration | 2.17e-04 | 56 | 43 | 3 | GO:0021795 | |
| GeneOntologyBiologicalProcess | retina vasculature morphogenesis in camera-type eye | 2.31e-04 | 11 | 43 | 2 | GO:0061299 | |
| GeneOntologyBiologicalProcess | mesenchymal cell proliferation | 2.53e-04 | 59 | 43 | 3 | GO:0010463 | |
| GeneOntologyBiologicalProcess | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway | 2.77e-04 | 12 | 43 | 2 | GO:1902237 | |
| GeneOntologyBiologicalProcess | regulation of PERK-mediated unfolded protein response | 3.26e-04 | 13 | 43 | 2 | GO:1903897 | |
| GeneOntologyBiologicalProcess | regulation of translation in response to endoplasmic reticulum stress | 3.26e-04 | 13 | 43 | 2 | GO:0036490 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | 3.46e-04 | 646 | 43 | 7 | GO:0005975 | |
| GeneOntologyBiologicalProcess | peptidyl-serine dephosphorylation | 4.38e-04 | 15 | 43 | 2 | GO:0070262 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation by eIF2 alpha phosphorylation | 4.38e-04 | 15 | 43 | 2 | GO:0010998 | |
| GeneOntologyBiologicalProcess | telencephalon cell migration | 4.55e-04 | 72 | 43 | 3 | GO:0022029 | |
| GeneOntologyBiologicalProcess | forebrain cell migration | 5.13e-04 | 75 | 43 | 3 | GO:0021885 | |
| GeneOntologyBiologicalProcess | layer formation in cerebral cortex | 5.66e-04 | 17 | 43 | 2 | GO:0021819 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic neurotransmitter receptor activity | 5.66e-04 | 17 | 43 | 2 | GO:0098962 | |
| GeneOntologyBiologicalProcess | glial cell migration | 6.20e-04 | 80 | 43 | 3 | GO:0008347 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation in response to stress | 6.36e-04 | 18 | 43 | 2 | GO:0043558 | |
| GeneOntologyBiologicalProcess | midbrain dopaminergic neuron differentiation | 6.36e-04 | 18 | 43 | 2 | GO:1904948 | |
| GeneOntologyBiologicalProcess | negative regulation of endoplasmic reticulum unfolded protein response | 7.10e-04 | 19 | 43 | 2 | GO:1900102 | |
| GeneOntologyBiologicalProcess | establishment of blood-brain barrier | 7.10e-04 | 19 | 43 | 2 | GO:0060856 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 7.59e-04 | 198 | 43 | 4 | GO:0048754 | |
| GeneOntologyBiologicalProcess | cell migration involved in gastrulation | 7.88e-04 | 20 | 43 | 2 | GO:0042074 | |
| GeneOntologyBiologicalProcess | PERK-mediated unfolded protein response | 8.69e-04 | 21 | 43 | 2 | GO:0036499 | |
| GeneOntologyBiologicalProcess | cellular response to cholesterol | 8.69e-04 | 21 | 43 | 2 | GO:0071397 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 9.61e-04 | 211 | 43 | 4 | GO:0060041 | |
| GeneOntologyCellularComponent | Wnt signalosome | 3.85e-06 | 16 | 41 | 3 | GO:1990909 | |
| GeneOntologyCellularComponent | Wnt-Frizzled-LRP5/6 complex | 3.74e-05 | 5 | 41 | 2 | GO:1990851 | |
| HumanPheno | Severe periodontitis | 7.87e-05 | 4 | 19 | 2 | HP:0000166 | |
| HumanPheno | Periodontitis | 7.87e-05 | 4 | 19 | 2 | HP:0000165 | |
| HumanPheno | Tortuosity of conjunctival vessels | 7.87e-05 | 4 | 19 | 2 | HP:0000503 | |
| Domain | Ldl_recept_b | 1.60e-08 | 14 | 39 | 4 | PF00058 | |
| Domain | LDLRB | 1.60e-08 | 14 | 39 | 4 | PS51120 | |
| Domain | LY | 2.18e-08 | 15 | 39 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.18e-08 | 15 | 39 | 4 | IPR000033 | |
| Domain | Aamy_C | 3.36e-08 | 4 | 39 | 3 | SM00632 | |
| Domain | Alpha_amylase | 3.36e-08 | 4 | 39 | 3 | IPR006046 | |
| Domain | Alpha-amylase_C | 8.39e-08 | 5 | 39 | 3 | PF02806 | |
| Domain | A-amylase/branching_C | 8.39e-08 | 5 | 39 | 3 | IPR006048 | |
| Domain | Aamy | 2.93e-07 | 7 | 39 | 3 | SM00642 | |
| Domain | Alpha-amylase | 2.93e-07 | 7 | 39 | 3 | PF00128 | |
| Domain | Glyco_hydro_13_cat_dom | 2.93e-07 | 7 | 39 | 3 | IPR006047 | |
| Domain | Glyco_hydro_catalytic_dom | 1.14e-06 | 38 | 39 | 4 | IPR013781 | |
| Domain | - | 1.27e-06 | 39 | 39 | 4 | 2.120.10.30 | |
| Domain | LDLR_class-A_CS | 1.41e-06 | 40 | 39 | 4 | IPR023415 | |
| Domain | Ldl_recept_a | 2.27e-06 | 45 | 39 | 4 | PF00057 | |
| Domain | - | 2.49e-06 | 46 | 39 | 4 | 4.10.400.10 | |
| Domain | 6-blade_b-propeller_TolB-like | 2.49e-06 | 46 | 39 | 4 | IPR011042 | |
| Domain | LDLRA_1 | 2.96e-06 | 48 | 39 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 3.21e-06 | 49 | 39 | 4 | IPR002172 | |
| Domain | LDLa | 3.21e-06 | 49 | 39 | 4 | SM00192 | |
| Domain | LDLRA_2 | 3.21e-06 | 49 | 39 | 4 | PS50068 | |
| Domain | Glyco_hydro_b | 3.76e-06 | 15 | 39 | 3 | IPR013780 | |
| Domain | NCK | 4.25e-06 | 2 | 39 | 2 | IPR017304 | |
| Domain | LRP5/6 | 4.25e-06 | 2 | 39 | 2 | IPR017049 | |
| Domain | Glycoside_hydrolase_SF | 4.42e-06 | 53 | 39 | 4 | IPR017853 | |
| Domain | A-amylase_C | 1.27e-05 | 3 | 39 | 2 | IPR031319 | |
| Domain | - | 5.26e-05 | 35 | 39 | 3 | 3.20.20.80 | |
| Domain | Glyco_hydro_13 | 6.34e-05 | 6 | 39 | 2 | IPR015902 | |
| Domain | EGF | 1.35e-04 | 126 | 39 | 4 | PF00008 | |
| Domain | - | 3.81e-04 | 14 | 39 | 2 | 2.60.40.1180 | |
| Domain | SH3_9 | 5.75e-04 | 78 | 39 | 3 | PF14604 | |
| Domain | EGF_CA | 1.15e-03 | 99 | 39 | 3 | PS01187 | |
| Domain | EGF_3 | 1.42e-03 | 235 | 39 | 4 | PS50026 | |
| Domain | EGF | 1.42e-03 | 235 | 39 | 4 | SM00181 | |
| Domain | EGF-like_dom | 1.76e-03 | 249 | 39 | 4 | IPR000742 | |
| Domain | EGF_1 | 1.92e-03 | 255 | 39 | 4 | PS00022 | |
| Domain | EGF-like_CS | 2.09e-03 | 261 | 39 | 4 | IPR013032 | |
| Domain | EGF-like_Ca-bd_dom | 2.19e-03 | 124 | 39 | 3 | IPR001881 | |
| Domain | EGF_2 | 2.21e-03 | 265 | 39 | 4 | PS01186 | |
| Domain | GPS | 2.29e-03 | 34 | 39 | 2 | SM00303 | |
| Domain | GPS | 2.42e-03 | 35 | 39 | 2 | PF01825 | |
| Domain | GPS | 2.56e-03 | 36 | 39 | 2 | PS50221 | |
| Domain | GPS | 2.70e-03 | 37 | 39 | 2 | IPR000203 | |
| Domain | SH3_1 | 4.82e-03 | 164 | 39 | 3 | PF00018 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 4.89e-03 | 50 | 39 | 2 | PS00650 | |
| Domain | 7tm_2 | 4.89e-03 | 50 | 39 | 2 | PF00002 | |
| Domain | GPCR_2-like | 6.97e-03 | 60 | 39 | 2 | IPR017981 | |
| Domain | GPCR_2_secretin-like | 6.97e-03 | 60 | 39 | 2 | IPR000832 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 7.19e-03 | 61 | 39 | 2 | PS50261 | |
| Domain | SH3 | 1.03e-02 | 216 | 39 | 3 | PS50002 | |
| Domain | SH3 | 1.03e-02 | 216 | 39 | 3 | SM00326 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_ | 3.98e-09 | 9 | 35 | 4 | M47622 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.04e-08 | 11 | 35 | 4 | M1091 | |
| Pathway | REACTOME_DIGESTION | 2.73e-07 | 23 | 35 | 4 | M27790 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 6.25e-07 | 28 | 35 | 4 | M27837 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 7.92e-06 | 52 | 35 | 4 | M14171 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.91e-05 | 72 | 35 | 4 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.07e-05 | 73 | 35 | 4 | MM15906 | |
| Pathway | PID_WNT_SIGNALING_PATHWAY | 4.40e-05 | 28 | 35 | 3 | M77 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 4.49e-05 | 161 | 35 | 5 | M39770 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS | 5.96e-05 | 5 | 35 | 2 | M48304 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 9.46e-05 | 36 | 35 | 3 | M39699 | |
| Pathway | KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY | 1.03e-04 | 37 | 35 | 3 | M47411 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY | 1.53e-04 | 110 | 35 | 4 | MM15977 | |
| Pathway | REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE | 1.66e-04 | 8 | 35 | 2 | MM14717 | |
| Pathway | REACTOME_SIGNALING_BY_RNF43_MUTANTS | 1.66e-04 | 8 | 35 | 2 | M27433 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 1.66e-04 | 8 | 35 | 2 | MM14976 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY | 1.98e-04 | 46 | 35 | 3 | M47409 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 2.13e-04 | 9 | 35 | 2 | MM14966 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.74e-04 | 57 | 35 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.94e-04 | 58 | 35 | 3 | M2049 | |
| Pathway | REACTOME_ACTIVATION_OF_RAC1 | 4.59e-04 | 13 | 35 | 2 | M6322 | |
| Pathway | KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4 | 5.35e-04 | 14 | 35 | 2 | M47834 | |
| Pathway | REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS | 6.16e-04 | 15 | 35 | 2 | M27273 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY | 7.96e-04 | 17 | 35 | 2 | M47728 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 1.11e-03 | 20 | 35 | 2 | MM15155 | |
| Pathway | REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION | 1.22e-03 | 21 | 35 | 2 | M27401 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY | 1.22e-03 | 21 | 35 | 2 | M47722 | |
| Pathway | REACTOME_DIGESTION | 1.22e-03 | 21 | 35 | 2 | MM15526 | |
| Pathway | WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA | 1.38e-03 | 89 | 35 | 3 | M39563 | |
| Pathway | WNT_SIGNALING | 1.38e-03 | 89 | 35 | 3 | M5493 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 1.47e-03 | 23 | 35 | 2 | M913 | |
| Pathway | REACTOME_DIGESTION_AND_ABSORPTION | 1.73e-03 | 25 | 35 | 2 | MM15557 | |
| Pathway | WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER | 1.81e-03 | 98 | 35 | 3 | M39731 | |
| Pathway | WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA | 1.87e-03 | 26 | 35 | 2 | M39407 | |
| Pathway | WP_WNT_SIGNALING_PATHWAY_AND_PLURIPOTENCY | 1.98e-03 | 101 | 35 | 3 | MM15829 | |
| Pathway | WP_WNT_SIGNALING_AND_PLURIPOTENCY | 1.98e-03 | 101 | 35 | 3 | M39387 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 2.02e-03 | 27 | 35 | 2 | MM14712 | |
| Pathway | PID_REELIN_PATHWAY | 2.17e-03 | 28 | 35 | 2 | M69 | |
| Pathway | REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION | 2.33e-03 | 29 | 35 | 2 | M779 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 2.66e-03 | 31 | 35 | 2 | M27400 | |
| Pathway | REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE | 2.66e-03 | 31 | 35 | 2 | MM15154 | |
| Pathway | PID_NEPHRIN_NEPH1_PATHWAY | 2.66e-03 | 31 | 35 | 2 | M193 | |
| Pathway | WP_WNT_SIGNALING_WP428 | 2.72e-03 | 113 | 35 | 3 | M39669 | |
| Pathway | WP_ESC_PLURIPOTENCY_PATHWAYS | 2.93e-03 | 116 | 35 | 3 | MM15863 | |
| Pathway | WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS | 3.01e-03 | 117 | 35 | 3 | M39530 | |
| Pathway | WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA | 3.01e-03 | 33 | 35 | 2 | M39870 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 3.08e-03 | 118 | 35 | 3 | M39852 | |
| Pathway | REACTOME_SIGNALING_BY_WNT_IN_CANCER | 3.20e-03 | 34 | 35 | 2 | M27405 | |
| Pathway | KEGG_LYSOSOME | 3.30e-03 | 121 | 35 | 3 | M11266 | |
| Pathway | PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY | 3.38e-03 | 35 | 35 | 2 | M127 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 3.78e-03 | 37 | 35 | 2 | M41819 | |
| Pathway | REACTOME_RHOV_GTPASE_CYCLE | 3.78e-03 | 37 | 35 | 2 | MM15610 | |
| Pathway | WP_ALZHEIMERS_DISEASE | 3.83e-03 | 261 | 35 | 4 | M42565 | |
| Pathway | PID_PDGFRB_PATHWAY | 3.96e-03 | 129 | 35 | 3 | M186 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 4.19e-03 | 39 | 35 | 2 | MM15607 | |
| Pathway | REACTOME_RHOU_GTPASE_CYCLE | 4.40e-03 | 40 | 35 | 2 | M41816 | |
| Pathway | WP_GENES_CONTROLLING_NEPHROGENESIS | 5.31e-03 | 44 | 35 | 2 | M39891 | |
| Pathway | PID_INSULIN_PATHWAY | 5.31e-03 | 44 | 35 | 2 | M16 | |
| Pathway | WP_WNT_SIGNALING_IN_KIDNEY_DISEASE | 5.31e-03 | 44 | 35 | 2 | MM15878 | |
| Pubmed | Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1. | 3.03e-11 | 6 | 43 | 4 | 6608795 | |
| Pubmed | 3.03e-11 | 6 | 43 | 4 | 2081604 | ||
| Pubmed | 3.03e-11 | 6 | 43 | 4 | 15286789 | ||
| Pubmed | 3.03e-11 | 6 | 43 | 4 | 2452973 | ||
| Pubmed | The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes. | 3.03e-11 | 6 | 43 | 4 | 2788608 | |
| Pubmed | 1.41e-10 | 8 | 43 | 4 | 12414807 | ||
| Pubmed | 8.32e-10 | 36 | 43 | 5 | 12412008 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 15299664 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 32697825 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 12527308 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 6176528 | ||
| Pubmed | State and trait variance in salivary α-amylase: a behavioral genetic study. | 1.76e-09 | 3 | 43 | 3 | 21827821 | |
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 30982860 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 22063648 | ||
| Pubmed | 1.76e-09 | 3 | 43 | 3 | 25588701 | ||
| Pubmed | Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland. | 7.04e-09 | 4 | 43 | 3 | 26132294 | |
| Pubmed | Characterization of the amino termini of mouse salivary and pancreatic amylases. | 7.04e-09 | 4 | 43 | 3 | 6165618 | |
| Pubmed | Multiple polyadenylation sites in a mouse alpha-amylase gene. | 7.04e-09 | 4 | 43 | 3 | 6166922 | |
| Pubmed | A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs. | 7.04e-09 | 4 | 43 | 3 | 6162570 | |
| Pubmed | Additional evidence for the close linkage of amy-1 and amy-2 in the mouse. | 7.04e-09 | 4 | 43 | 3 | 6163812 | |
| Pubmed | Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity. | 7.04e-09 | 4 | 43 | 3 | 26098870 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 6160849 | ||
| Pubmed | Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini. | 7.04e-09 | 4 | 43 | 3 | 2987507 | |
| Pubmed | Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus. | 7.04e-09 | 4 | 43 | 3 | 4745489 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 6091898 | ||
| Pubmed | Gentic polymorphism of amylase isoenzymes in feral populations of the house mouse. | 7.04e-09 | 4 | 43 | 3 | 1141004 | |
| Pubmed | Genetic variation in mouse salivary amylase rate of synthesis. | 7.04e-09 | 4 | 43 | 3 | 94264 | |
| Pubmed | Genetic regulation of GM4(NeuAc) expression in mouse erythrocytes. | 7.04e-09 | 4 | 43 | 3 | 2332419 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 3872721 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 6157477 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 6176715 | ||
| Pubmed | Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences. | 7.04e-09 | 4 | 43 | 3 | 6162108 | |
| Pubmed | Simultaneous expression of salivary and pancreatic amylase genes in cultured mouse hepatoma cells. | 7.04e-09 | 4 | 43 | 3 | 2431276 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 16152770 | ||
| Pubmed | Independent regulation of nonallelic pancreatic amylase genes in diabetic mice. | 7.04e-09 | 4 | 43 | 3 | 6207174 | |
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 2423416 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 2410924 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 2476716 | ||
| Pubmed | 7.04e-09 | 4 | 43 | 3 | 6161122 | ||
| Pubmed | Expression of mouse Amy-2a alpha-amylase genes is regulated by strong pancreas-specific promoters. | 7.04e-09 | 4 | 43 | 3 | 3877171 | |
| Pubmed | Mouse alpha-amylase loci, Amy-1a and Amy-2a, are closely linked. | 7.04e-09 | 4 | 43 | 3 | 2989529 | |
| Pubmed | MESD is essential for apical localization of megalin/LRP2 in the visceral endoderm. | 1.19e-08 | 21 | 43 | 4 | 21337463 | |
| Pubmed | Genetic mapping of the IL-12 alpha chain gene (Il12a) on mouse chromosome 3. | 1.76e-08 | 5 | 43 | 3 | 8661735 | |
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 6529441 | ||
| Pubmed | Murine Salivary Amylase Protects Against Streptococcus mutans-Induced Caries. | 1.76e-08 | 5 | 43 | 3 | 34276419 | |
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 6176569 | ||
| Pubmed | 1.76e-08 | 5 | 43 | 3 | 1348427 | ||
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 7946325 | ||
| Pubmed | Ampd-2 maps to distal mouse chromosome 3 in linkage with Ampd-1. | 3.51e-08 | 6 | 43 | 3 | 2328996 | |
| Pubmed | Genetics of hydroxyacid oxidase isozymes in the mouse: localisation of Hao-2 on linkage group XVI. | 3.51e-08 | 6 | 43 | 3 | 284003 | |
| Pubmed | A fibrillar collagen gene, Col11a1, is essential for skeletal morphogenesis. | 3.51e-08 | 6 | 43 | 3 | 7859283 | |
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 2002257 | ||
| Pubmed | 3.51e-08 | 6 | 43 | 3 | 2450406 | ||
| Pubmed | The mouse urate oxidase gene, Uox, maps to distal chromosome 3. | 3.51e-08 | 6 | 43 | 3 | 9250879 | |
| Pubmed | Linkage of the cadmium resistance locus to loci on mouse chromosome 12. | 3.51e-08 | 6 | 43 | 3 | 1021597 | |
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 6160178 | ||
| Pubmed | Rostral cerebellar malformation, (rcm): a new recessive mutation on chromosome 3 of the mouse. | 6.14e-08 | 7 | 43 | 3 | 1401878 | |
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 8604219 | ||
| Pubmed | Analysis of the mouse Amy locus in recombinant inbred mouse strains. | 6.14e-08 | 7 | 43 | 3 | 2451911 | |
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 8666240 | ||
| Pubmed | 6.14e-08 | 7 | 43 | 3 | 7949740 | ||
| Pubmed | 9.82e-08 | 8 | 43 | 3 | 2824476 | ||
| Pubmed | Linkage relationships among eleven biochemical loci in Peromyscus. | 9.82e-08 | 8 | 43 | 3 | 6200103 | |
| Pubmed | 9.82e-08 | 8 | 43 | 3 | 8486361 | ||
| Pubmed | Murine VCAM-1. Molecular cloning, mapping, and analysis of a truncated form. | 9.82e-08 | 8 | 43 | 3 | 7523515 | |
| Pubmed | 9.82e-08 | 8 | 43 | 3 | 2040456 | ||
| Pubmed | 9.82e-08 | 8 | 43 | 3 | 3038891 | ||
| Pubmed | 1.47e-07 | 9 | 43 | 3 | 93520 | ||
| Pubmed | Two-hybrid analysis of human salivary mucin MUC7 interactions. | 1.47e-07 | 9 | 43 | 3 | 16203048 | |
| Pubmed | 2.10e-07 | 10 | 43 | 3 | 9121556 | ||
| Pubmed | 2.10e-07 | 10 | 43 | 3 | 2897103 | ||
| Pubmed | Mouse R-cadherin: expression during the organogenesis of pancreas and gastrointestinal tract. | 2.88e-07 | 11 | 43 | 3 | 7493641 | |
| Pubmed | 2.88e-07 | 11 | 43 | 3 | 23449223 | ||
| Pubmed | Four loci from human chromosome 1 are physically assigned to sheep chromosome 1p. | 2.88e-07 | 11 | 43 | 3 | 8589528 | |
| Pubmed | 2.88e-07 | 11 | 43 | 3 | 24639464 | ||
| Pubmed | Salivary protein profiles are linked to bitter taste acceptance in infants. | 2.88e-07 | 11 | 43 | 3 | 24248522 | |
| Pubmed | 2.88e-07 | 11 | 43 | 3 | 2903254 | ||
| Pubmed | 2.88e-07 | 11 | 43 | 3 | 2565740 | ||
| Pubmed | 2.88e-07 | 11 | 43 | 3 | 7608209 | ||
| Pubmed | 2.88e-07 | 11 | 43 | 3 | 1617215 | ||
| Pubmed | 3.84e-07 | 12 | 43 | 3 | 21185284 | ||
| Pubmed | 3.84e-07 | 12 | 43 | 3 | 8144363 | ||
| Pubmed | Assignment of the mouse homologues of 6 loci from HSA1p to chromosomes 3 and 4. | 4.99e-07 | 13 | 43 | 3 | 7829080 | |
| Pubmed | 4.99e-07 | 13 | 43 | 3 | 489953 | ||
| Pubmed | Stage-specific association of apolipoprotein A-I and E in developing mouse retina. | 6.35e-07 | 14 | 43 | 3 | 17389516 | |
| Pubmed | 6.35e-07 | 14 | 43 | 3 | 2902233 | ||
| Pubmed | 6.35e-07 | 14 | 43 | 3 | 7894156 | ||
| Pubmed | Syntenic assignment of human chromosome 1 homologous loci in the bovine. | 6.35e-07 | 14 | 43 | 3 | 8001974 | |
| Pubmed | 9.75e-07 | 16 | 43 | 3 | 2571572 | ||
| Pubmed | 9.75e-07 | 16 | 43 | 3 | 10842072 | ||
| Pubmed | Mesenchymal Wnt signaling promotes formation of sternum and thoracic body wall. | 1.18e-06 | 17 | 43 | 3 | 25727890 | |
| Pubmed | 1.18e-06 | 17 | 43 | 3 | 25410786 | ||
| Pubmed | 1.42e-06 | 18 | 43 | 3 | 34446743 | ||
| Pubmed | 1.42e-06 | 18 | 43 | 3 | 2338144 | ||
| Pubmed | 1.49e-06 | 2 | 43 | 2 | 28219410 | ||
| Pubmed | LRP5/6 directly bind to Frizzled and prevent Frizzled-regulated tumour metastasis. | 1.49e-06 | 2 | 43 | 2 | 25902418 | |
| Pubmed | Wnt-Lrp5 signaling regulates fatty acid metabolism in the osteoblast. | 1.49e-06 | 2 | 43 | 2 | 25802278 | |
| Pubmed | Evidence against a human cell-specific role for LRP6 in anthrax toxin entry. | 1.49e-06 | 2 | 43 | 2 | 18350154 | |
| Pubmed | Low density lipoprotein receptor related protein 1 and 6 gene variants and ischaemic stroke risk. | 1.49e-06 | 2 | 43 | 2 | 26031789 | |
| Pubmed | Localization of the gene causing autosomal dominant osteopetrosis type I to chromosome 11q12-13. | 1.49e-06 | 2 | 43 | 2 | 12054167 | |
| Interaction | WNT3A interactions | 2.64e-06 | 49 | 40 | 4 | int:WNT3A | |
| Interaction | PRSS37 interactions | 3.24e-06 | 15 | 40 | 3 | int:PRSS37 | |
| Interaction | NMS interactions | 2.83e-05 | 30 | 40 | 3 | int:NMS | |
| Interaction | HTN3 interactions | 2.83e-05 | 30 | 40 | 3 | int:HTN3 | |
| Interaction | DAB1 interactions | 5.92e-05 | 107 | 40 | 4 | int:DAB1 | |
| Interaction | LYZL1 interactions | 8.67e-05 | 118 | 40 | 4 | int:LYZL1 | |
| Interaction | THBS1 interactions | 1.15e-04 | 127 | 40 | 4 | int:THBS1 | |
| Interaction | ST8SIA5 interactions | 1.25e-04 | 49 | 40 | 3 | int:ST8SIA5 | |
| Interaction | AMY2B interactions | 1.71e-04 | 10 | 40 | 2 | int:AMY2B | |
| Cytoband | 1p21 | 6.99e-09 | 24 | 43 | 4 | 1p21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1p21 | 3.21e-06 | 107 | 43 | 4 | chr1p21 | |
| Cytoband | 3p22.1 | 6.53e-04 | 40 | 43 | 2 | 3p22.1 | |
| Cytoband | 11q13.2 | 9.02e-04 | 47 | 43 | 2 | 11q13.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr5q32 | 2.59e-03 | 80 | 43 | 2 | chr5q32 | |
| GeneFamily | Low density lipoprotein receptors | 3.26e-09 | 13 | 28 | 4 | 634 | |
| GeneFamily | SH2 domain containing | 1.06e-02 | 101 | 28 | 2 | 741 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 3.61e-06 | 399 | 43 | 7 | M41172 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-08 | 181 | 43 | 6 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.10e-08 | 181 | 43 | 6 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_2|Control_saline / Treatment groups by lineage, cell group, cell type | 1.39e-06 | 200 | 43 | 5 | bc8949eb34482aca166c4602ff6ab876cb4c2c3c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.21e-05 | 171 | 43 | 4 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 3.08e-05 | 186 | 43 | 4 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | 15-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 3.21e-05 | 188 | 43 | 4 | 4963382e54aac06bf5047c7d725393db70667ee7 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.34e-05 | 190 | 43 | 4 | 136ca6da77a202874376af193a1dd71d810c76c4 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-Pericytes|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.48e-05 | 192 | 43 | 4 | 7aadc7c5bd03274f9861dde2febda5c37f8afc9c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-05 | 193 | 43 | 4 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-05 | 193 | 43 | 4 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.63e-05 | 194 | 43 | 4 | 78dcb9d48259afabe73b41c5508a73a8d62339a4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 195 | 43 | 4 | dd281a249854800f737dc22e0f375f66dfb5cf5f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-05 | 195 | 43 | 4 | 49c99553629cdd83ee56a2e508d5bc8d34b8507b | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.70e-05 | 195 | 43 | 4 | fc43cd295f2cc3f6e9442232e028944f011c82cc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.70e-05 | 195 | 43 | 4 | d760d1423f9a8a373fe7b250ea9b1d67a0c0059f | |
| ToppCell | ILEUM-non-inflamed-(8)_Pericytes|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.77e-05 | 196 | 43 | 4 | b98fe1519e420d8b03c66e164bf4544f3dbb2e44 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-05 | 197 | 43 | 4 | 4d63a274828ebb951db78421c2823453d862cd49 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-05 | 197 | 43 | 4 | 452be45f4aac8459dd860493171f5f715368d663 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-05 | 197 | 43 | 4 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.85e-05 | 197 | 43 | 4 | b11a5d909942a4299cbc0b27332b1a3f66f3bccd | |
| ToppCell | COVID-19-kidney-Fibroblast-2|kidney / Disease (COVID-19 only), tissue and cell type | 3.93e-05 | 198 | 43 | 4 | ca26ca460856b1faaa3e83766da6abdf63af2b51 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-05 | 198 | 43 | 4 | abac765c4f6864bdb1700bc546c3b9771edc25c3 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-05 | 198 | 43 | 4 | ff57addcbdd53e5d2d0c80ec76b5eab3b3a67ca2 | |
| ToppCell | 3'-Adult-LymphNode-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.93e-05 | 198 | 43 | 4 | 698166b4ca173176ed563af6a1efc8c7d0a18e0b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_immature-Tip-like-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.00e-05 | 199 | 43 | 4 | 1295f34a350bf48987e2fad411aaac3630efd3f1 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-05 | 199 | 43 | 4 | bd9b36dcf61eaa628ce1b70d21c5783b64c29e8f | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.00e-05 | 199 | 43 | 4 | e751eb67510f8a5842dcfed44134160919cdb713 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 4.08e-05 | 200 | 43 | 4 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_B2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-04 | 153 | 43 | 3 | 82a96ca1912858c4311b87b3b0ba5a0a41e564b5 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 153 | 43 | 3 | e426db29e4ba83e7930dc88c74fc975b177c9540 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 153 | 43 | 3 | 668eacd76aad6054bd7d57e3af0b122c2443465f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Myeloid-macrophage|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 153 | 43 | 3 | 4b999892fb797e9f0d391630094f466463299d57 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-04 | 155 | 43 | 3 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 158 | 43 | 3 | a2efcc184ef13d81373e3690253ba35f6be09c5f | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-Endothelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 158 | 43 | 3 | ba9998cbf786c515d30fe42de02c7a246db1b6f9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Endothelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 158 | 43 | 3 | e52eff2bd1e7e0ce9c278ed5109802865e0fe69c | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Club_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.09e-04 | 162 | 43 | 3 | aed15eef32419b8a4e2afdb9776c2bf2802e96f1 | |
| ToppCell | tumor_Lung-T/NK_cells-Cytotoxic_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 5.27e-04 | 164 | 43 | 3 | 60fe6bb86afaebd92590135f08f5434ce0d8d73c | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.46e-04 | 166 | 43 | 3 | f5ee7270820a8b8d85d51b4019b2b8c2beb87fc2 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-04 | 166 | 43 | 3 | b7f303203068b205f382788815df487a0ea148ed | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.66e-04 | 168 | 43 | 3 | 7abaddbcc55e44653d54aa15464266aa6bd5c9d2 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Epithelial-neuro-epithelial-EC_cells_(TAC1+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.66e-04 | 168 | 43 | 3 | 17d46f993dc4ae22b8087808582aba77f5c61892 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-04 | 169 | 43 | 3 | 8bfa2d3bb541d02f55d7c95b8fd156c8403befca | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-04 | 169 | 43 | 3 | bb43abad2c049b7f4d307737347290e01b3339a3 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.75e-04 | 169 | 43 | 3 | 5f18e3f40a5b1b167903f37516ec8181e889c7c5 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 5.95e-04 | 171 | 43 | 3 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-NK_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.06e-04 | 172 | 43 | 3 | f3c16a62eba1ed190318beee131c71c5150b266a | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-04 | 173 | 43 | 3 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.16e-04 | 173 | 43 | 3 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | TCGA-Brain-Primary_Tumor|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.16e-04 | 173 | 43 | 3 | f6ba22661e67c17d49d1058d4170ba8f36bf47f0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C_(NP)-Glut_NP_L5/6_FEZF2-Exc_L5-6_FEZF2_MYBPHL|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.16e-04 | 173 | 43 | 3 | b002b22f9968b5967d29fe0eab4e796d87b355fa | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.26e-04 | 174 | 43 | 3 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.26e-04 | 174 | 43 | 3 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-04 | 175 | 43 | 3 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | Dividing_Macrophages-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 6.37e-04 | 175 | 43 | 3 | 0a8bf455babb3271aa00642199fb58b0b02dc3ac | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-04 | 175 | 43 | 3 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.37e-04 | 175 | 43 | 3 | 0992de1c7bffcb6890584357a7a0a8955927da6c | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.47e-04 | 176 | 43 | 3 | 270d7908dbd84028958d257f94941dc685e20255 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.47e-04 | 176 | 43 | 3 | e4b21fd6a5e0c5950f27c3e1868318e48330ae5e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.58e-04 | 177 | 43 | 3 | 382f0d6bbff01e84b0c7840e74ac865864e6da89 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-04 | 177 | 43 | 3 | a8625d14682183cf77cb51eaf11bc15a3528f586 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.58e-04 | 177 | 43 | 3 | cdfd2f0ee2f692271b1525e414b0f645cdadb1f6 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.6.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.58e-04 | 177 | 43 | 3 | 929cd8f530ce001623735da53b7278d02522e2b5 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-04 | 177 | 43 | 3 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 6.58e-04 | 177 | 43 | 3 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.58e-04 | 177 | 43 | 3 | 3645e2f4a48283f290f85c49c3e79e3f58ac9aa6 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 6.58e-04 | 177 | 43 | 3 | db222faaecbe5600da39277243c4e7e764eb63c9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.58e-04 | 177 | 43 | 3 | 4c069f0d044a96118090b85ca592a21d6b5d9399 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-M/X_cells_(MLN/GHRL+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.58e-04 | 177 | 43 | 3 | c80893e5cf5688ee9f5afc8f11b3890f296c9e1f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-04 | 178 | 43 | 3 | d4ecb84e9b1f4ec49c519321156aa10f9bd34cce | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.69e-04 | 178 | 43 | 3 | 0b398656f26c4061b11ccf98908d0e2e1367585a | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-04 | 178 | 43 | 3 | 93ce73f8bcec63ebf86fabb546f88400e8f06465 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.80e-04 | 179 | 43 | 3 | e880c507f11ce75d104593a4ca29f0295f8125e8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.80e-04 | 179 | 43 | 3 | f65889bf1e41396979cce44a5e63f49dea2bbd9b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.02e-04 | 181 | 43 | 3 | 08f44323bf71b6004a921bbc969c954c75feeb66 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_CCL3+-Alveolar_macrophage_CCL3+_L.1.0.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.02e-04 | 181 | 43 | 3 | a8d4b2340d99734bf9379b467fb481c598b9b4fb | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.13e-04 | 182 | 43 | 3 | 4234d0cc57b5266a5e03133c75c7918abe48465e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-04 | 182 | 43 | 3 | 44764676ed3f51ba171ce63f669390392fa50a43 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.13e-04 | 182 | 43 | 3 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.13e-04 | 182 | 43 | 3 | d82f59a3f930a840dde27dc6ab024f227a26d446 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-04 | 183 | 43 | 3 | 9533db4db2c6ae78d7ca1682cf4efed12183396f | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.25e-04 | 183 | 43 | 3 | bf7f1cb55ed55981b8b355d5774055c96e658ff2 | |
| ToppCell | tumor_Lung-Fibroblasts-Pericytes|tumor_Lung / Location, Cell class and cell subclass | 7.25e-04 | 183 | 43 | 3 | a03dd563af9b15cb1f5de5732a229405a9f82d84 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.25e-04 | 183 | 43 | 3 | 65f2a5895d166189a095cf7ea9dda171f0419b08 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L1-3_PVALB_WFDC2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.36e-04 | 184 | 43 | 3 | c4c1a3d279ca733b865ce46570d7642dc137f9a4 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.36e-04 | 184 | 43 | 3 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.36e-04 | 184 | 43 | 3 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.48e-04 | 185 | 43 | 3 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-Progenitor_(NEUROG3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.48e-04 | 185 | 43 | 3 | 2088e82e0febdcf05618d3db913d00e2e87812f4 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus_-18m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-04 | 186 | 43 | 3 | f3345fad9559ec222062a6f516b9d3f815d98acf | |
| ToppCell | facs-Brain_Myeloid-Hippocampus_-18m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-04 | 186 | 43 | 3 | 77baa0075e53ccb654a561e3289eba41deab8561 | |
| ToppCell | Thalamus-Endothelial|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.60e-04 | 186 | 43 | 3 | dcc6e4417c4123d5ca6b96fa8ca4874626aaebdb | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.60e-04 | 186 | 43 | 3 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | TCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9 | 7.60e-04 | 186 | 43 | 3 | e8580a2093eb7e50aad55ec7fada850d2fed8ae1 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus_|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-04 | 186 | 43 | 3 | eb1d1941cd6e4d9f0655aff3ba8df3c29c06b3a2 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus_-18m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-04 | 186 | 43 | 3 | 06e6e805f90d92c870f36b79fa0749988a4595bb | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.60e-04 | 186 | 43 | 3 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.60e-04 | 186 | 43 | 3 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus_-18m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-04 | 186 | 43 | 3 | 28699e3574d3a183190bdb6c5db2219167d41579 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.60e-04 | 186 | 43 | 3 | 0c477016c1b539b3086a8066c3c6443f08c222a3 | |
| Drug | 4,6-O-3-ketobutylidene maltopentaose | 1.50e-10 | 6 | 42 | 4 | CID003083414 | |
| Drug | R 623 | 1.50e-10 | 6 | 42 | 4 | CID003027594 | |
| Drug | dimethylaminomethylferrocene | 1.50e-10 | 6 | 42 | 4 | CID000102082 | |
| Drug | mono-6-deoxy-6-fluorocyclomaltoheptaose | 1.50e-10 | 6 | 42 | 4 | CID000127364 | |
| Drug | CNP-G3 | 1.50e-10 | 6 | 42 | 4 | CID003082910 | |
| Drug | AC1L5BOU | 3.49e-10 | 7 | 42 | 4 | CID000174858 | |
| Drug | BG5P | 3.49e-10 | 7 | 42 | 4 | CID003082752 | |
| Drug | desethylaprophen | 6.96e-10 | 8 | 42 | 4 | CID000163919 | |
| Drug | azintamide | 6.96e-10 | 8 | 42 | 4 | CID000071105 | |
| Drug | alpha-maltosyl fluoride | 1.25e-09 | 9 | 42 | 4 | CID000194237 | |
| Drug | trestatin A | 1.25e-09 | 9 | 42 | 4 | CID003054994 | |
| Drug | AC1LAC07 | 2.08e-09 | 10 | 42 | 4 | CID000485275 | |
| Drug | Glc)4 | 2.08e-09 | 10 | 42 | 4 | CID000189098 | |
| Drug | Ro 20-0083 | 2.08e-09 | 10 | 42 | 4 | CID003082332 | |
| Drug | AC1L3M0Q | 2.08e-09 | 10 | 42 | 4 | CID000118008 | |
| Drug | validamycin D | 3.27e-09 | 11 | 42 | 4 | CID000166726 | |
| Drug | FG5P | 3.27e-09 | 11 | 42 | 4 | CID000127486 | |
| Drug | CNP-G5 | 3.27e-09 | 11 | 42 | 4 | CID000127309 | |
| Drug | HgI2 | 3.27e-09 | 11 | 42 | 4 | CID000024485 | |
| Drug | 2C KM | 3.27e-09 | 11 | 42 | 4 | CID009549196 | |
| Drug | azaprophen | 4.90e-09 | 12 | 42 | 4 | CID000129486 | |
| Drug | AC1N3UXZ | 5.84e-09 | 3 | 42 | 3 | CID004118625 | |
| Drug | methyl 1'-epiacarviosin | 7.06e-09 | 13 | 42 | 4 | CID000197426 | |
| Drug | isoacarbose | 7.06e-09 | 13 | 42 | 4 | CID000449165 | |
| Drug | Cyclodextrins | 9.88e-09 | 14 | 42 | 4 | CID000024238 | |
| Drug | terephthaloyl chloride | 9.88e-09 | 14 | 42 | 4 | CID000007488 | |
| Drug | 2-chloro-4-nitrophenol | 9.88e-09 | 14 | 42 | 4 | CID000012074 | |
| Drug | 4-nitrophenylmaltoheptaoside | 1.34e-08 | 15 | 42 | 4 | CID000173254 | |
| Drug | gamma-cyclodextrin | 1.79e-08 | 16 | 42 | 4 | CID000086575 | |
| Drug | Bay e 4609 | 1.79e-08 | 16 | 42 | 4 | CID003085308 | |
| Drug | 2-nitropropyl acetate | 2.33e-08 | 4 | 42 | 3 | CID013573844 | |
| Drug | N-PMT | 2.33e-08 | 4 | 42 | 3 | CID000194224 | |
| Drug | Dembrexine | 2.33e-08 | 4 | 42 | 3 | CID000072009 | |
| Drug | g lw | 2.33e-08 | 4 | 42 | 3 | CID000444139 | |
| Drug | AC1MQT4V | 2.33e-08 | 4 | 42 | 3 | CID003482066 | |
| Drug | beta-santalene | 2.33e-08 | 4 | 42 | 3 | CID000010534 | |
| Drug | SAIB-SG | 2.33e-08 | 4 | 42 | 3 | CID002735139 | |
| Drug | trimitan | 3.00e-08 | 18 | 42 | 4 | CID000005561 | |
| Drug | aprophen | 3.00e-08 | 18 | 42 | 4 | CID000071128 | |
| Drug | pg 6 | 4.74e-08 | 20 | 42 | 4 | CID000070931 | |
| Drug | actinidine | 5.82e-08 | 5 | 42 | 3 | CID000068231 | |
| Drug | Deposiston | 5.82e-08 | 5 | 42 | 3 | CID003080829 | |
| Drug | 2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid | 5.82e-08 | 5 | 42 | 3 | CID010358258 | |
| Drug | 2TAA | 5.82e-08 | 5 | 42 | 3 | CID000127374 | |
| Drug | cimicifugic acid A | 5.82e-08 | 5 | 42 | 3 | CID006449879 | |
| Drug | silver perchlorate | 5.82e-08 | 5 | 42 | 3 | CID000024562 | |
| Drug | lunularic acid | 5.82e-08 | 5 | 42 | 3 | CID000161413 | |
| Drug | himachalene | 5.82e-08 | 5 | 42 | 3 | CID000015095 | |
| Drug | AC1L4DZ4 | 5.82e-08 | 5 | 42 | 3 | CID000155287 | |
| Drug | AC1L3XPY | 5.85e-08 | 21 | 42 | 4 | CID000124005 | |
| Drug | maltosaccharide | 7.14e-08 | 22 | 42 | 4 | CID005461034 | |
| Drug | Panose B | 1.03e-07 | 24 | 42 | 4 | CID000439297 | |
| Drug | mannan | 1.08e-07 | 63 | 42 | 5 | CID000000870 | |
| Drug | 2-amino-6-picoline | 1.16e-07 | 6 | 42 | 3 | CID000015765 | |
| Drug | phenol blue | 1.16e-07 | 6 | 42 | 3 | CID000075078 | |
| Drug | Gu-4 | 1.16e-07 | 6 | 42 | 3 | CID000448679 | |
| Drug | (2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid | 1.16e-07 | 6 | 42 | 3 | CID009577343 | |
| Drug | Borane dimethylamine complex | 1.16e-07 | 6 | 42 | 3 | CID009898794 | |
| Drug | AC1L3OV4 | 1.16e-07 | 6 | 42 | 3 | CID000092801 | |
| Drug | AC1OAGH8 | 1.16e-07 | 6 | 42 | 3 | CID006857368 | |
| Drug | vermella | 1.16e-07 | 6 | 42 | 3 | CID000203726 | |
| Drug | hymenin | 1.16e-07 | 6 | 42 | 3 | CID000010499 | |
| Drug | tris(hydroxyethyl)aminomethane | 1.16e-07 | 6 | 42 | 3 | CID000448009 | |
| Drug | mercuric thiocyanate | 1.16e-07 | 6 | 42 | 3 | CID000011615 | |
| Drug | CID439354 | 1.23e-07 | 25 | 42 | 4 | CID000439354 | |
| Drug | C13H9cl2NO5 | 1.70e-07 | 27 | 42 | 4 | CID004369477 | |
| Drug | 3KBG5CNP | 2.03e-07 | 7 | 42 | 3 | CID003083250 | |
| Drug | AC1L9UU3 | 2.03e-07 | 7 | 42 | 3 | CID000071762 | |
| Drug | Paramax | 2.03e-07 | 7 | 42 | 3 | CID000156411 | |
| Drug | methyl blue | 2.03e-07 | 7 | 42 | 3 | CID011969534 | |
| Drug | amino-methyl | 2.03e-07 | 7 | 42 | 3 | CID000142005 | |
| Drug | calcium cyanamide | 2.30e-07 | 29 | 42 | 4 | CID010920500 | |
| Drug | N,N'-disalicylidene-1,3-diaminopropane | 2.65e-07 | 30 | 42 | 4 | CID005373003 | |
| Drug | boric acid gel | 3.25e-07 | 8 | 42 | 3 | CID003016474 | |
| Drug | AC1NSVJM | 3.25e-07 | 8 | 42 | 3 | CID005317411 | |
| Drug | theodrenaline | 3.25e-07 | 8 | 42 | 3 | CID000071857 | |
| Drug | N-vinylcaprolactam | 3.25e-07 | 8 | 42 | 3 | CID000075227 | |
| Drug | 9-azidoacridine | 3.25e-07 | 8 | 42 | 3 | CID000146692 | |
| Drug | acrinor | 3.25e-07 | 8 | 42 | 3 | CID005489637 | |
| Drug | Triap | 3.25e-07 | 8 | 42 | 3 | CID000013356 | |
| Drug | rhodanile blue | 3.25e-07 | 8 | 42 | 3 | CID000073372 | |
| Drug | NSC300622 | 3.25e-07 | 8 | 42 | 3 | CID000028426 | |
| Drug | Folin Marenzi reagent | 3.46e-07 | 32 | 42 | 4 | CID000452313 | |
| Drug | gallium | 3.62e-07 | 80 | 42 | 5 | CID000105145 | |
| Drug | R625 | 3.94e-07 | 33 | 42 | 4 | CID000072375 | |
| Drug | AC1NNF4R | 4.46e-07 | 34 | 42 | 4 | CID005067795 | |
| Drug | Atonik | 4.87e-07 | 9 | 42 | 3 | CID000069471 | |
| Drug | GSAD | 4.87e-07 | 9 | 42 | 3 | CID009909127 | |
| Drug | GU-3 | 4.87e-07 | 9 | 42 | 3 | CID000448687 | |
| Drug | zingiberene | 4.87e-07 | 9 | 42 | 3 | CID000092776 | |
| Drug | H 187 | 4.87e-07 | 9 | 42 | 3 | CID000001742 | |
| Drug | mercuric nitrate | 4.87e-07 | 9 | 42 | 3 | CID000024864 | |
| Drug | PNPC | 5.02e-07 | 35 | 42 | 4 | CID000165125 | |
| Drug | KSCN | 6.32e-07 | 37 | 42 | 4 | CID000516872 | |
| Drug | BCDs | 6.32e-07 | 37 | 42 | 4 | CID000364214 | |
| Drug | I ZE | 6.94e-07 | 10 | 42 | 3 | CID009549200 | |
| Drug | trans-cinnamamide | 6.94e-07 | 10 | 42 | 3 | CID000012135 | |
| Drug | CG-120 | 6.94e-07 | 10 | 42 | 3 | CID000171403 | |
| Drug | naphthalene-1,3,6,8-tetrol | 6.94e-07 | 10 | 42 | 3 | CID000440202 | |
| Drug | eicosa-11,14-dienoic acid | 6.94e-07 | 10 | 42 | 3 | CID000003208 | |
| Disease | alpha-amylase 1 measurement | 2.24e-07 | 9 | 42 | 3 | EFO_0801371 | |
| Disease | Nephrotic Syndrome | 7.66e-06 | 27 | 42 | 3 | C0027726 | |
| Disease | Shortened QT interval | 1.08e-04 | 11 | 42 | 2 | C0151879 | |
| Disease | Migraine Disorders | 1.53e-04 | 13 | 42 | 2 | C0149931 | |
| Disease | schizophrenia, irritable bowel syndrome | 2.65e-04 | 17 | 42 | 2 | EFO_0000555, MONDO_0005090 | |
| Disease | myocardial infarction (is_implicated_in) | 3.82e-04 | 99 | 42 | 3 | DOID:5844 (is_implicated_in) | |
| Disease | Albuminuria | 5.35e-04 | 24 | 42 | 2 | C0001925 | |
| Disease | migraine disorder, pulse pressure measurement | 6.29e-04 | 26 | 42 | 2 | EFO_0005763, MONDO_0005277 | |
| Disease | spontaneous coronary artery dissection | 8.96e-04 | 31 | 42 | 2 | EFO_0010820 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SSSFGRWPKGQTMWA | 71 | Q8IZF5 | |
| GRYKWDAWNSLGKMS | 66 | Q8NC06 | |
| FFWMGSDSWGSKIAP | 306 | Q14833 | |
| YSKPGSWGSFWAMLT | 6 | A6NE02 | |
| YLKNWGEGWGFMPSD | 291 | P0DTE7 | |
| YLKNWGEGWGFMPSD | 291 | P0DTE8 | |
| GKPRPGMSSWWSSDD | 286 | Q9P1A6 | |
| KMPWKTCWRYLTSGG | 976 | O60706 | |
| YLKNWGEGWGFMPSD | 291 | P0DUB6 | |
| YLKNWGEGWGFMPSD | 291 | P19961 | |
| PSGWSSLWIGYSFVM | 1571 | P02462 | |
| KPLSGSDRAWMWLAS | 2096 | P49792 | |
| WKRGCANMTYRWGTL | 261 | Q9NW15 | |
| GYDVWMGNSRGNTWS | 111 | Q5VXI9 | |
| SGSWVMSRVWDNGYP | 216 | P31513 | |
| KGKEGMGAWPTWSRY | 116 | Q96KX0 | |
| MEKCSDGWWRGSYNG | 136 | P16333 | |
| MEKCSDGWWRGSYNG | 141 | O43639 | |
| WMSNKRSLSPWGYSI | 91 | Q9UHF5 | |
| LRGTMYWSDWGNHPK | 4011 | Q07954 | |
| DWMGKNLYWADTGTN | 726 | O75197 | |
| PNAWMSDSGTGLTYW | 201 | Q99550 | |
| DPSSGFMYWTDWGEV | 146 | O75581 | |
| DPAEGFMYWTEWGGK | 756 | O75581 | |
| GSYSEWSMTPRFTPW | 141 | Q969J5 | |
| LCAGRWWEYMPSGFT | 76 | Q6PIJ6 | |
| LGGSSAYTWVRGWEM | 331 | Q96A29 | |
| MWAAGRWGPTFPSSY | 1 | Q96HJ3 | |
| SASGMDYWIVKNSWG | 416 | P53634 | |
| IWYWSMRLQARGGPS | 656 | Q9Y653 | |
| PSWASLEYGGKWKML | 666 | O00462 | |
| PAAYFWRKGWLSRGM | 166 | Q7KZN9 | |
| WLPAGSTSGLLKSMW | 106 | A6NEL3 | |
| MDSGPWDLGKQWSSA | 336 | A0A1W2PPM1 | |
| RPWGKDNYWMLNPNS | 186 | Q9C009 | |
| RGFMYWSDWGDQAKI | 551 | Q14114 | |
| SLWQKMRQYPGSWAE | 641 | Q96C24 | |
| SWSGMLHSNPGDYAW | 166 | Q9Y4L5 | |
| PDMRNYAKRKGWWDG | 201 | Q0VDG4 | |
| KRMPWGWDYSGSSNL | 616 | Q9NZC9 | |
| TKAMWEAWGNPSSPY | 51 | Q96I15 | |
| PEVNSSWWYMRATGG | 21 | P09544 | |
| GEPATWMTFLISYWG | 211 | Q13488 | |
| DYNSWMKGCGWVPFG | 951 | P20929 |